Lei Gan

732 total citations
29 papers, 544 citations indexed

About

Lei Gan is a scholar working on Cancer Research, Oncology and Immunology. According to data from OpenAlex, Lei Gan has authored 29 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Lei Gan's work include Cancer, Hypoxia, and Metabolism (4 papers), Neuroblastoma Research and Treatments (3 papers) and Cancer Cells and Metastasis (3 papers). Lei Gan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Neuroblastoma Research and Treatments (3 papers) and Cancer Cells and Metastasis (3 papers). Lei Gan collaborates with scholars based in China, Canada and United Kingdom. Lei Gan's co-authors include Ruijuan Xiu, Guoliang Qing, Ping Ren, Yue Ming, Daibiao Xiao, Hudan Liu, Zhixiang Zhuang, Rui Xia, Zegeng Li and Jing Sun and has published in prestigious journals such as Oncogene, Frontiers in Immunology and The Journal of Pathology.

In The Last Decade

Lei Gan

24 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Gan China 13 340 225 93 57 56 29 544
Yan Long United States 11 306 0.9× 208 0.9× 132 1.4× 30 0.5× 30 0.5× 16 574
Huai‐Xiang Hao United States 8 490 1.4× 363 1.6× 85 0.9× 43 0.8× 56 1.0× 8 822
Anping Song China 10 306 0.9× 95 0.4× 99 1.1× 68 1.2× 46 0.8× 15 527
Xiuye Ma United States 15 388 1.1× 246 1.1× 74 0.8× 43 0.8× 60 1.1× 32 571
Portia S. Lombardo United States 3 500 1.5× 451 2.0× 71 0.8× 60 1.1× 22 0.4× 3 727
Shuijie Li China 13 248 0.7× 139 0.6× 96 1.0× 40 0.7× 57 1.0× 31 466
Alicia Zukas United States 9 170 0.5× 99 0.4× 153 1.6× 79 1.4× 35 0.6× 21 687
Johann Matschke Germany 13 380 1.1× 224 1.0× 58 0.6× 143 2.5× 27 0.5× 26 563
Victoria A. Elliott United Kingdom 11 378 1.1× 315 1.4× 246 2.6× 47 0.8× 19 0.3× 15 735

Countries citing papers authored by Lei Gan

Since Specialization
Citations

This map shows the geographic impact of Lei Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Gan more than expected).

Fields of papers citing papers by Lei Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Gan. The network helps show where Lei Gan may publish in the future.

Co-authorship network of co-authors of Lei Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Gan. A scholar is included among the top collaborators of Lei Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Gan. Lei Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Weng, Jui‐Hung, Shicheng Li, Jui‐Hung Weng, et al.. (2025). Bioinspired 3D hydrogel scaffold to mimic tumor microenvironment for investigating into the anoikis resistance mechanisms in colorectal cancer. Materials Today Bio. 33. 102061–102061.
3.
Hu, Yiqing, Zhigang Chen, Min Yao, & Lei Gan. (2025). Immunotherapy Rechallenge of Advanced NSCLC with Acquired EGFR T790M Mutation after EGFR-TKI Therapy: A Case Report. Cancer Management and Research. Volume 17. 2623–2629.
4.
Gan, Lei, Xiaoning He, & Jing Wu. (2025). Impact of moderate and severe exacerbations on clinical prognosis and economic burden of chronic obstructive pulmonary disease in China. Expert Review of Pharmacoeconomics & Outcomes Research. 25(10). 1411–1419.
5.
Zhang, Fubin, et al.. (2025). FTO triggers NLRP3/GSDMD-dependent pyroptosis to enhance cisplatin-sensitivity in ovarian cancer. Cellular Signalling. 131. 111698–111698. 1 indexed citations
6.
Gan, Lei, et al.. (2023). Identification of molecular subtypes and immune infiltration in endometriosis: a novel bioinformatics analysis and In vitro validation. Frontiers in Immunology. 14. 1130738–1130738. 7 indexed citations
7.
Gan, Lei, Heyue Du, Qiukui Hao, et al.. (2023). Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults. International Journal of Technology Assessment in Health Care. 39(1). e53–e53. 6 indexed citations
10.
Lu, Jiajie, Xiaoning Guo, Shujun Chen, et al.. (2021). P2X4R Contributes to Central Disinhibition Via TNF-α/TNFR1/GABAaR Pathway in Post-stroke Pain Rats. Journal of Pain. 22(8). 968–980. 14 indexed citations
11.
Tang, Min, Peiqing Liu, Xiaoke Wu, et al.. (2021). COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing’s Sarcoma. BioMed Research International. 2021(1). 7453500–7453500. 9 indexed citations
12.
Wang, Qiaoyun, Shuai Zhao, Lei Gan, & Zhixiang Zhuang. (2020). Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer. Bioscience Reports. 40(9). 23 indexed citations
13.
Gan, Lei, et al.. (2020). <p>Synergistic Effect of 3-Bromopyruvate in Combination with Rapamycin Impacted Neuroblastoma Metabolism by Inhibiting Autophagy</p>. OncoTargets and Therapy. Volume 13. 11125–11137. 10 indexed citations
14.
Xia, Rui, Tao Xie, Bing Liu, et al.. (2019). <p>Dexamethasone inhibits the proliferation of tumor cells</p>. Cancer Management and Research. Volume 11. 1141–1154. 20 indexed citations
15.
Lu, Haifeng, Lei Zhang, Lei Gan, et al.. (2018). A new central post-stroke pain rat model: autologous blood injected thalamic hemorrhage involved increased expression of P2X4 receptor. Neuroscience Letters. 687. 124–130. 15 indexed citations
16.
Yang, Chen, Huan Wu, Xinheng Wang, et al.. (2018). Huaier Granule extract inhibit the proliferation and metastasis of lung cancer cells through down-regulation of MTDH, JAK2/STAT3 and MAPK signaling pathways. Biomedicine & Pharmacotherapy. 101. 311–321. 44 indexed citations
17.
Wang, Chengyang, et al.. (2017). Effect of Liuweibuqi capsules on the balance between MMP-9 and TIMP1 and viability of alveolar macrophages in COPD. Bioscience Reports. 37(5). 7 indexed citations
18.
Zhuang, Zhixiang, et al.. (2017). Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting. Artificial Cells Nanomedicine and Biotechnology. 46(8). 1–8. 37 indexed citations
19.
Wang, Chengyang, et al.. (2017). Effect of Liuweibuqi Capsules in Pulmonary Alveolar Epithelial Cells and COPD Through JAK/STAT Pathway. Cellular Physiology and Biochemistry. 43(2). 743–756. 17 indexed citations
20.
Li, Wenwen, Guoxian Long, Dongbo Liu, et al.. (2014). Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity.. PubMed. 69(2). 132–7. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026